InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
77.19
(
1.14%
)
Bitcoin
58,553.72
(
2.14%
)
Post# of 253009
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: DewDiligence post# 44851

Friday, 04/13/2007 9:23:28 AM

Friday, April 13, 2007 9:23:28 AM

Post# of 253009
A few comments/questions.

1. With MEDI 's potential buy-out value of 10B+, how does this affect valuations of other similar biotechs? If MEDI is worth 10B+ in a buyout, then BIIB would appear undervalued (IMO).

2. Any possibility of a large cap bio (like AMGN) being a bidder for MEDI.

3. Any ideas on how a MEDI buy-out would be structured (cash, stock, both)? I would think it would be an all cash deal.

biophud
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up